Optimization of Heart Failure Pharmacotherapy
Investigating clinical strategies to maximize the efficacy and safety of heart failure medication regimens.
15 Selected Publications
- Management of Iron Deficiency in Heart Failure: Practical Considerations and Implementation of Evidence-Based Iron Supplementation
- Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure
- Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure
- Drug-Induced Takotsubo Cardiomyopathy
- Severe Hypertriglyceridemia Induced by Sirolimus Treated With Medical Management Without Plasmapheresis: A Case Report
- Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndrome
- Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin
- Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy
- Sacubitril/Valsartan Off-Label Uses for Heart Failure
- Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials
- Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis
- Economic Impact of Ambulatory Clinical Pharmacists in an Advanced Heart Failure Clinic
- Evaluating Sacubitril/Valsartan Dose Dependence on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
- Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy
- Chronologic Changes and Correlates of Loop Diuretic Dose in Patients with Left Ventricular Assist Device